5[1]Julius S.Autonomic nervous system dyregulation in hypertension[J].Am J Cardiol,1991,67:3B-7B.
6[2]Tusji H,Venditti F J,Jr Menders E S,et al.Determinants of HRV in systemic hypertension[J].Am J Cardioal,1996,77:1073-1077.
7[3]Tsazuki S,Matoba T,Eyuchis A,et al.Angiotensin Ⅱ type 2 receptor inhibits cell proliferation and activited tyrosine phosphatase[J].Hypertension,1996,28:916-918.
8[5]Juhamru K E,Airakainen H T,Antti Y,et al.Heart rate variability and coronary artery disease[J].Am J Cardiol,1999,83:1000-1005.
9中国高血压防治指南起草委员会.中国高血压防治指南.高血压杂志,2000,:94-112.
10Chalmers J.WHO - ISH Hypertension Guidelines Committee.1999 World Health Organization International Society of Hypertension Guidelines for the Management of Hypertension.J Hypertension,1999,17(2):151 ～ 183.
4Strom BL, Anderson CA, Ix JH. Sodium reduction in populations : insights from the institute of medicine committee [ J ]. JAMA, 2013,310( 1 ) :31 -32.
5Mccarron DA, Kasaks AG, Geerling JC, et al. Normal range of human dietary sodium intake : a perspective based on 24 - hour u- rinary sodium excretion worldwide[ J]. Am J Hypertens,2013,26 (10) :1218 - 1223.
6Liu Z. Dietary sodium and the incidence of hypertension in the Chinese population : a review of nationwide surveys[ J]. Am J Hy- pertens, 2009,22 ( 9 ) :929 - 933.
7Zhang Z, Cogswell ME, Gillespie C, et al. Association between usual sodium and potassium intake and blood pressure and hyper- tension among US adults : NHANES 2005 - 2010 [ J ]. PLoS One, 2013,8(10) :e75289.
8Whehon PK, He J. Health effects of sodium and potassium in hu- mans[ J]. Curr Opin Lipidol,2014,25( 1 ) :75 -79.
9He FJ, Li J, Macgregor GA. Effect of longer-term modest salt re- duction on blood pressure [J]. Coehrane Database Syst Rev, 2013,4 : CD004937.
10Karppanen H, Tanskanen A, Tuomilehto J, et al. Safety and effects of potassium-and magnesium-containing low sodium salt mixtures[ J]. J Cardiovasc Pharmacol, 1984,6 ( Suppl 1 ) : S236 - S243.
